242 related articles for article (PubMed ID: 17443608)
1. Cotrimoxazole for prophylaxis or treatment of opportunistic infections of HIV/AIDS in patients with previous history of hypersensitivity to cotrimoxazole.
Lin D; Li WK; Rieder MJ
Cochrane Database Syst Rev; 2007 Apr; (2):CD005646. PubMed ID: 17443608
[TBL] [Abstract][Full Text] [Related]
2. Cotrimoxazole prophylaxis for opportunistic infections in adults with HIV.
Grimwade K; Swingler ; G
Cochrane Database Syst Rev; 2003; 2003(3):CD003108. PubMed ID: 12917946
[TBL] [Abstract][Full Text] [Related]
3. Cotrimoxazole prophylaxis for opportunistic infections in children with HIV infection.
Grimwade K; Swingler GH
Cochrane Database Syst Rev; 2006 Jan; 2006(1):CD003508. PubMed ID: 16437457
[TBL] [Abstract][Full Text] [Related]
4. Cotrimoxazole prophylaxis for opportunistic infections in children with HIV infection.
Grimwade K; Swingler G
Cochrane Database Syst Rev; 2003; (2):CD003508. PubMed ID: 12804472
[TBL] [Abstract][Full Text] [Related]
5. Impact of tuberculosis preventive therapy on tuberculosis and mortality in HIV-infected children.
Gray DM; Zar H; Cotton M
Cochrane Database Syst Rev; 2009 Jan; (1):CD006418. PubMed ID: 19160285
[TBL] [Abstract][Full Text] [Related]
6. Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients.
Stern A; Green H; Paul M; Vidal L; Leibovici L
Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD005590. PubMed ID: 25269391
[TBL] [Abstract][Full Text] [Related]
7. Prevention of diarrhoea in children with HIV infection or exposure to maternal HIV infection.
Humphreys EH; Smith NA; Azman H; McLeod D; Rutherford GW
Cochrane Database Syst Rev; 2010 Jun; (6):CD008563. PubMed ID: 20556793
[TBL] [Abstract][Full Text] [Related]
8. TNF, LTA, HSPA1L and HLA-DR gene polymorphisms in HIV-positive patients with hypersensitivity to cotrimoxazole.
Alfirevic A; Vilar FJ; Alsbou M; Jawaid A; Thomson W; Ollier WE; Bowman CE; Delrieu O; Park BK; Pirmohamed M
Pharmacogenomics; 2009 Apr; 10(4):531-40. PubMed ID: 19374512
[TBL] [Abstract][Full Text] [Related]
9. Management of toxoplasmic encephalitis in HIV-infected adults (with an emphasis on resource-poor settings).
Dedicoat M; Livesley N
Cochrane Database Syst Rev; 2006 Jul; (3):CD005420. PubMed ID: 16856096
[TBL] [Abstract][Full Text] [Related]
10. Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients.
Green H; Paul M; Vidal L; Leibovici L
Cochrane Database Syst Rev; 2007 Jul; (3):CD005590. PubMed ID: 17636808
[TBL] [Abstract][Full Text] [Related]
11. [Seven hours for effective and safe desensitization in HIV-positive patients intolerant to cotrimoxazole].
El Benaye J; Nihal B; Hicham J; Mohamed E
Pan Afr Med J; 2014; 18():238. PubMed ID: 25426196
[No Abstract] [Full Text] [Related]
12. Cost-effectiveness of cotrimoxazole prophylaxis among persons with HIV in Uganda.
Pitter C; Kahn JG; Marseille E; Lule JR; McFarland DA; Ekwaru JP; Bunnell R; Coutinho A; Mermin J
J Acquir Immune Defic Syndr; 2007 Mar; 44(3):336-43. PubMed ID: 17327758
[TBL] [Abstract][Full Text] [Related]
13. Interventions for the treatment of decreased bone mineral density associated with HIV infection.
Lin D; Rieder MJ
Cochrane Database Syst Rev; 2007 Apr; (2):CD005645. PubMed ID: 17443607
[TBL] [Abstract][Full Text] [Related]
14. Successful desensitization to dapsone for Pneumocystis carinii prophylaxis in an HIV-positive patient.
Cook DE; Kossey JL
Ann Pharmacother; 1998 Dec; 32(12):1302-5. PubMed ID: 9876811
[TBL] [Abstract][Full Text] [Related]
15. Trimethoprim-sulfamethoxazole oral desensitization in hemophiliacs infected with human immunodeficiency virus with a history of hypersensitivity reactions.
Kletzel M; Beck S; Elser J; Shock N; Burks W
Am J Dis Child; 1991 Dec; 145(12):1428-9. PubMed ID: 1688295
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the impact of cotrimoxazole prophylaxis on key outcomes among HIV-infected adults in low- and middle-income countries: a systematic review.
Saadani Hassani A; Marston BJ; Kaplan JE
J Acquir Immune Defic Syndr; 2015 Apr; 68 Suppl 3(Suppl 3):S257-69. PubMed ID: 25768865
[TBL] [Abstract][Full Text] [Related]
17. A randomized, pilot trial comparing full versus escalating dose regimens for the desensitization of AIDS patients allergic to sulfonamides.
Straatmann A; Bahia F; Pedral-Sampaio D; Brites C
Braz J Infect Dis; 2002 Dec; 6(6):276-80. PubMed ID: 12585970
[TBL] [Abstract][Full Text] [Related]
18. Sulfa hypersensitivity in patients with HIV infection: onset, treatment, critical review of the literature.
Ryan C; Madalon M; Wortham DW; Graziano FM
WMJ; 1998 May; 97(5):23-7. PubMed ID: 9617304
[TBL] [Abstract][Full Text] [Related]
19. Prophylaxis of Pneumocystis pneumonia in immunocompromised non-HIV-infected patients: systematic review and meta-analysis of randomized controlled trials.
Green H; Paul M; Vidal L; Leibovici L
Mayo Clin Proc; 2007 Sep; 82(9):1052-9. PubMed ID: 17803871
[TBL] [Abstract][Full Text] [Related]
20. Feasibility and effectiveness of cotrimoxazole prophylaxis for HIV-1-infected adults attending an HIV/AIDS clinic in Uganda.
Watera C; Todd J; Muwonge R; Whitworth J; Nakiyingi-Miiro J; Brink A; Miiro G; Antvelink L; Kamali A; French N; Mermin J
J Acquir Immune Defic Syndr; 2006 Jul; 42(3):373-8. PubMed ID: 16810124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
